ID: ALA90924

Max Phase: Preclinical

Molecular Formula: C12H13NO5

Molecular Weight: 251.24

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCOC(=O)c1ccc(NC(=O)C(=O)OC)cc1

Standard InChI:  InChI=1S/C12H13NO5/c1-3-18-11(15)8-4-6-9(7-5-8)13-10(14)12(16)17-2/h4-7H,3H2,1-2H3,(H,13,14)

Standard InChI Key:  RIUAUOKYXCJRIL-UHFFFAOYSA-N

Associated Targets(non-human)

P4ha1 Prolyl 4-hydroxylase alpha-1 subunit (36 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 251.24Molecular Weight (Monoisotopic): 251.0794AlogP: 0.97#Rotatable Bonds: 3
Polar Surface Area: 81.70Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 10.37CX Basic pKa: CX LogP: 1.91CX LogD: 1.91
Aromatic Rings: 1Heavy Atoms: 18QED Weighted: 0.64Np Likeness Score: -0.83

References

1. Cunliffe CJ, Franklin TJ, Hales NJ, Hill GB..  (1992)  Novel inhibitors of prolyl 4-hydroxylase. 3. Inhibition by the substrate analogue N-oxaloglycine and its derivatives.,  35  (14): [PMID:1321909] [10.1021/jm00092a016]

Source